Aspects of leptin in anorexia nervosa: possible beneficial effects on the treatment of hyperactivity

Authors

  • Silvana Soriano FRASSETTO Universidade Luterana do Brasil
  • Graziela Oliveira de BITENCOURT Universidade Luterana do Brasil

Keywords:

Anorexia nervosa, Hyperkinesis, Hormones. Leptin, Adipose tissue

Abstract

Recent studies have demonstrated a direct relationship between leptin and the regulation of energy balance, and as a factor involved in eating disorders. Acting on the central nervous system, leptin affects food intake, glucose metabolism, body weight, the production of sexual hormones, and physical activity. Studies with humans and animals indicate that low leptin levels are related to symptoms of anorexia nervosa: low food intake, excessive loss of body weight, amenorrhea and hyperactivity. Thus, the degree of hypoleptinemia is not only a strong indication of low reserves of adipose tissue, but also of a severe disorder, and leptin levels can
be used to better evaluate the seriousness of the disease. Research has aimed to study the use of leptin in the treatment of patients with AN, and positive results have been obtained in the reduction of hyperactivity. It is possible that leptin treatment associated with medication and psychotherapy can be beneficial for extremely active anorexia nervosa patients, making them more susceptible to further treatment. Adequate food intake, medication, psychotherapy, and a comfortable environment during leptin treatment should be ensured. Thus, this article aims to describe leptin and aspects related to anorexia, and discuss how this information can be
important in the clinical evaluation of patients with this eating disorder.

References

Zhang YY, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional of the mouse obese gene and its human homolog. Nature. 1994; 372(6505):425-32.

Havel PJ. Mechanisms regulating leptin production: implications for control of energy balance. Am J Clin Nutr. 1999; 70(3):305-6.

Negrão AB, Licinio J. Leptina: o diálogo entre adipócitos e neurônios. Arq Bras Endocrinol Metab. 2000; 44(3):205-14.

Banks WA, Lebel CR. Strategies for the delivery of leptin to the CNS. J Drug Target. 2002; 10(4): 297-308.

Niswender KD, Schwartz MW. Insulin and leptin revisited: adiposity signals with overlapping physiology and intracellular signaling capabilities. Front Neuroendocrinol. 2003; 24(1):1-10.

Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowels NG, Carr DR, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations. Diabetes. 2002; 51(4):1005-15.

Velkoska E, Morris MJ, Burns P, Weisinger RS. Leptin reduces food intake but does not alter weight regain following food deprivation in the rat. Int J Obes. 2003; 27(1):48-54.

Park KG, Park KS, Kim MJ, Kim HS, Suh YS, Ahn JD, et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract. 2004; 63(2):135-42.

Havel PJ. Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med. 2001; 226(11):963-77.

Blevins JE, Schwartz MW, Baskin DG. Peptide signals regulating food intake and energy homeostasis. Can J Physiol Pharmacol. 2002; 80(5): 396-406.

Schwartz MW, Woods SC, Porte DJR, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000; 404(6778):661-71.

Hinney A, Bornscheuer A, Depenbusch M, Mierke B, Tolle A, Middeke K, et al. No evidence for involvement of the leptin gene in anorexia nervosa, bulimia nervosa, underweight or early onset extreme obesity: identification of two novel mutations in the coding sequence and a novel polymorphism in the leptin gene linked upstream region. Mol Psychiatry. 1998; 3(6):539-43.

Hebebrand J, Muller TD, Holtkamp K, Herpertz-Dahlmann B. The role of leptin in anorexia nervosa: clinical implications. Mol Psychiatry. 2007; 12(1):23-35.

DSM-IV-TRTM. Manual diagnóstico e estatístico de transtornos mentais. 4a. ed. Porto Alegre: Artmed; 2002.

Organização Mundial de Saúde. Classificação de transtornos mentais e de comportamento da CID-10. Descrições clínicas e diretrizes diagnósticas. Porto Alegre: Artes Médicas; 1993.

Eckert E, Pomeroy C, Raymond N, Kohler PF, Thuras P, Bowers CY. Leptin in anorexia nervosa. J Clin Endocrinol Metab. 1998; 83(3):791-5.

Gendall KA, Kaye WH, Altemus M, McConaha CW, La Via MC. Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients. Biol Psychiatry. 1999; 46(2):292-9.

Krivoza J, Papezova H, Haluzikova D, Parizkova J, Jiskra J, Kotrli Haas T, et al. Soluble leptin receptor levels in patients with anorexia nervosa. Endocrinol Res. 2002; 28(3):199-205.

Polito A, Jabbri A, Ferro-Luzzi A, Cuzzolaro M, Censi L, Ciarapica D, et al. Basal metabolic rate in anorexia nervosa: relation to body composition and leptin concentration. Am J Clin Nutr. 2000; 71(6): 1495-502.

Janeckova R. The role of leptin in human physiology and pathophysiology. Physiol Res. 2001; 50(5):443-59.

Holtkamp K, Hebebrand J, Mika C, Herr M, Heussen N, Herpertz-Dahlmann B. High serum leptin levels subsequent to weight gain predict renewed weight loss in patients with anorexia nervosa. Psychoneuroendocrinology. 2004; 29(6):791-97.

Hebebrand J, Blum WF, Barth N, Coners H, Englaro P, Juul A, et al. Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Mol Psychiatry. 1997; 2(4):330-4.

Baranowka B, Radzikowska M, WasilewskaDziubinska E, Roguski K, Borowiec M. Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity. Diabetes Obes Metab. 2000; 2(2):99-103.

Inui A. Eating behavior in anorexia nervosa: an excess of both orexigenic and anorexigenic signaling? Mol Psychiatry. 2001; 6(6):620-4.

Goumenou AG, Matalliotakis IM, Koumantakis GE, Panidis DK. The role of leptin in fertility. Eur J Obstetr Ginecol Reprod Biol. 2003; 106(2):118-24.

Tolle V, Kaden M, Bluet-Pajot MT, Jure D, Foulon C, Bossu C, et al. Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. J Clin Endocrinol Metab. 2003; 88(1):109-16.

Licinio J, Negrão AB, Mantzoros C. Sex differences in circulating human leptin pulse amplitude: clinical implications. J Clin Endocrinal Metab. 1998; 83(11):4140-7.

Brambilla F, Monteleone P, Bortolotti F, Dalle Grave R, Todisco P, Javaro A, et al. Persistent amenorrhoea in weight-recovered anorexics: psychological and biological aspects. Psychiatry Res. 2003; 118(3): 249-57.

Hebebrand J, Exner C, Hebebrand K, Holtkamp C, Casper RC, Remschmidt H, et al. Hyperactivity in patients with anorexia nervosa and in semi-starved rats: evidence for a pivotal role of hypoleptinemia. Physiol Behav. 2003; 79(1):25-37.

Holtkamp K, Herpertz-Dahlmann B, Mika C, Heer M, Heussen N, Fichter M, et al. Elevated physical activity and low leptin levels co-occur in patients with anorexia nervosa. J Clin Endocrinol Metab. 2003; 88(11):5169-74.

Hebebrand J, Casper R, Treasure J, Schweiger U. The need to revise the diagnostic criteria for anorexia nervosa. J Neural Transm. 2004; 111(7): 827-40.

Davis C, Katzman DK, Kaptein S, Kirsh C, Brewer H, Kalmbach K, et al. The prevalence of high-level exercise in the eating disorders: etiological implications. Compr Psychiatry. 1997; 38(6): 321-26.

Elmquist JK, Maratos-Flier E, Saper CB, Flier JS. Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci. 1998; 1(6):445-50.

Müller TD, Föcker M, Holtkamp K, Herpertz-Dahlmann B, Hebebrand J. Leptin-mediated neuroendocrine alterations in anorexia nervosa: somatic and behavioral implications. Child Adolesc Psychiatric Clin N Am. 2008; 18(1):117-29.

Lanfranco F, Gianotti L, Destefanis S, Arvat E, Ghigo E, Camanni F. Endocrine abnormalities in anorexia nervosa. Minerva Endocrinol. 2003; 28(2):169-80.

Bamber D, Cockerill IM, Carroll D. The pathological status of exercise dependence. Br J Sports Med. 2000; 34(2):125-32.

Exner C, Hebebrand J, Remschmidt H, Wewetzer C, Ziegler A, Herpertz S, et al. Leptin suppresses semi-starvation induced hyperactivity in rats: implications for anorexia nervosa. Mol Psychiatry. 2000; 5(5):476-81.

Hillebrand JJ, Koeners MP, de Rijke CE, Kas MJ, Adan RA. Leptin treatment in activity-based anorexia. Biol Psychiatry. 2005; 58(2):165-71.

Baranowska B, Baranowska-Bik A, Bik W, Martynska L. The role of leptin and orexins in the dysfunction of hypothalamo-pituitary-gonadal regulation and in the mechanism of hyperactivity in patients with anorexia. Neuro Endocrinol Lett. 2008; 29(1):37-40.

Södersten P, Bergh C, Zandian M. Psychoneuroendocrinology of anorexia nervosa. Psychoneuroendocrinology. 2006; 31(10):1149-53.

Published

2023-08-31

How to Cite

Soriano FRASSETTO, S., & Oliveira de BITENCOURT, G. . (2023). Aspects of leptin in anorexia nervosa: possible beneficial effects on the treatment of hyperactivity. Brazilian Journal of Nutrition, 22(5). Retrieved from https://periodicos.puc-campinas.edu.br/nutricao/article/view/9526